Streetbeat News

Analyst Ratings

LADR

Ladder Cap (NYSE:LADR) reported Q2 earnings of $0.33 per share, beating the analyst consensus estimate of $0.32 by 3.13%. However, this is a 2.94% decrease from the same period last year. The company's quarterly sales were $74.15 million, missing the analyst consensus estimate of $98.89 million by 25.02%, and marking an 11.58% decrease from the same period last year.

Portfolio Pulse from sunil@benzinga.com

July 26, 2023 | 9:20 pm

AEM

Agnico Eagle Mines reported Q2 adjusted earnings of $0.65 per share, beating the analyst consensus estimate of $0.56 by 16.07%. The company also reported quarterly sales of $1.718 billion, surpassing the analyst consensus estimate of $1.71 billion by 0.47%. This represents an 8.67% increase over sales of $1.58 billion in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 9:05 pm

MEOH

Methanex (NASDAQ:MEOH) reported Q2 earnings of $0.60 per share, beating the analyst consensus estimate of $0.57 by 5.26%. The company also reported quarterly sales of $939.00 million, surpassing the analyst consensus estimate of $892.08 million by 5.26%. However, this represents a 17.41% decrease over sales of $1.14 billion in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 9:03 pm

IBTX

Independent Bank Gr (NASDAQ:IBTX) has received mixed analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 1 indifferent. The average price target is $44.4, slightly below the current price of $44.82, implying a potential downside. This represents a 2.95% decrease from the previous average price target of $45.75.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 9:00 pm

GATX

In the last quarter, analysts have provided somewhat bullish ratings for GATX (NYSE:GATX) with an average 12-month price target of $136.5, an increase of 6.43% from the previous average price target of $128.25.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 9:00 pm

KROS

Keros Therapeutics (NASDAQ:KROS) has received positive analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish ratings. The average 12-month price target for the company is $93.75, a decrease of 21.88% from the previous average of $120.00.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 9:00 pm

OHI

Over the past 3 months, 5 analysts have published their opinion on Omega Healthcare Invts (NYSE:OHI) stock. The average price target is $32.2, slightly below the current price of $32.24. The average price target has increased by 1.42% over the past month.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 9:00 pm

CVBF

CVB Financial (NASDAQ:CVBF) reported Q2 earnings of $0.40 per share, beating the analyst consensus estimate of $0.38 by 5.26%. However, this is a 4.76% decrease from the same period last year. The company also reported quarterly sales of $132.19 million, beating the analyst consensus estimate of $120.23 million by 9.95%, but this is a 3.23% decrease from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

July 26, 2023 | 8:56 pm

HUM

A significant bearish stance has been taken on Humana (NYSE:HUM) by a large investor, as observed in the options history. The overall sentiment of these big-money traders is split between 35% bullish and 64% bearish. Whales have been targeting a price range from $410.0 to $490.0 for Humana over the last 3 months. The price of HUM is down -1.35% at $448.21. Several financial institutions have given their ratings and price targets for Humana.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 8:47 pm

ALGN

A whale investor has taken a bullish stance on Align Tech (NASDAQ:ALGN), with 57% of investors opening trades with bullish expectations and 42% with bearish. The whale has been targeting a price range from $280.0 to $400.0 for Align Tech over the last 3 months. The price of ALGN is up 2.32% at $339.85. The next earnings are expected to be released in 0 days.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 8:47 pm